
Titan Medical Inc
TSX:TMD

Intrinsic Value
The intrinsic value of one
TMD
stock under the Base Case scenario is
0.005
CAD.
Compared to the current market price of 0.045 CAD,
Titan Medical Inc
is
Overvalued by 88%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Titan Medical Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Titan Medical Inc
Balance Sheet Decomposition
Titan Medical Inc
Current Assets | 4.4m |
Cash & Short-Term Investments | 3.9m |
Other Current Assets | 546k |
Non-Current Assets | 70k |
Other Non-Current Assets | 70k |
Free Cash Flow Analysis
Titan Medical Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Titan Medical Inc
Revenue
|
950k
USD
|
Operating Expenses
|
-3.2m
USD
|
Operating Income
|
-2.3m
USD
|
Other Expenses
|
-2.8m
USD
|
Net Income
|
-5m
USD
|
TMD Profitability Score
Profitability Due Diligence
Titan Medical Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Score
Titan Medical Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.
TMD Solvency Score
Solvency Due Diligence
Titan Medical Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Score
Titan Medical Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TMD Price Targets Summary
Titan Medical Inc
Dividends
Current shareholder yield for TMD is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
TMD
stock under the Base Case scenario is
0.005
CAD.
Compared to the current market price of 0.045 CAD,
Titan Medical Inc
is
Overvalued by 88%.